Prudential Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $66.2M | Buy |
133,294
+1,734
| +1% | +$768K | 0.07% | 194 |
|
|
2026
Q1 | $58.7M | Sell |
131,560
-3,059
| -2% | -$1.43M | 0.07% | 207 |
|
|
2025
Q4 | $61M | Sell |
134,619
-91,195
| -40% | -$39.3M | 0.07% | 200 |
|
|
2025
Q3 | $88.4M | Buy |
225,814
+45,578
| +25% | +$19M | 0.11% | 165 |
|
|
2025
Q2 | $80.2M | Buy |
180,236
+11,381
| +7% | +$5.24M | 0.1% | 168 |
|
|
2025
Q1 | $81.9M | Buy |
168,855
+717
| +0.4% | +$334K | 0.12% | 151 |
|
|
2024
Q4 | $67.7M | Sell |
168,138
-42,095
| -20% | -$19.5M | 0.09% | 171 |
|
|
2024
Q3 | $97.8M | Sell |
210,233
-79,409
| -27% | -$38.1M | 0.14% | 139 |
|
|
2024
Q2 | $136M | Buy |
289,642
+34,181
| +13% | +$14.8M | 0.2% | 93 |
|
|
2024
Q1 | $107M | Buy |
255,461
+4,642
| +2% | +$1.96M | 0.15% | 129 |
|
|
2023
Q4 | $99.6M | Sell |
250,819
-53,122
| -17% | -$19.6M | 0.15% | 131 |
|
|
2023
Q3 | $106M | Sell |
303,941
-170,512
| -36% | -$59.6M | 0.17% | 124 |
|
|
2023
Q2 | $167M | Sell |
474,453
-59,395
| -11% | -$20M | 0.24% | 75 |
|
|
2023
Q1 | $168M | Sell |
533,848
-146,638
| -22% | -$44M | 0.26% | 74 |
|
|
2022
Q4 | $197M | Sell |
680,486
-38,436
| -5% | -$11.7M | 0.33% | 65 |
|
|
2022
Q3 | $208M | Buy |
718,922
+13,296
| +2% | +$3.83M | 0.35% | 56 |
|
|
2022
Q2 | $199M | Sell |
705,626
-43,229
| -6% | -$11.6M | 0.32% | 65 |
|
|
2022
Q1 | $195M | Buy |
748,855
+88,350
| +13% | +$21M | 0.26% | 74 |
|
|
2021
Q4 | $145M | Buy |
660,505
+49,727
| +8% | +$9.67M | 0.18% | 122 |
|
|
2021
Q3 | $114M | Buy |
610,778
+177,000
| +41% | +$34.6M | 0.16% | 139 |
|
|
2021
Q2 | $87.5M | Buy |
433,778
+140,680
| +48% | +$29.4M | 0.12% | 171 |
|
|
2021
Q1 | $63M | Sell |
293,098
-198,252
| -40% | -$43.5M | 0.09% | 207 |
|
|
2020
Q4 | $116M | Sell |
491,350
-17,532
| -3% | -$4.02M | 0.2% | 109 |
|
|
2020
Q3 | $138M | Sell |
508,882
-210,505
| -29% | -$58.1M | 0.26% | 86 |
|
|
2020
Q2 | $209M | Sell |
719,387
-28,493
| -4% | -$7.72M | 0.4% | 51 |
|
|
2020
Q1 | $178M | Buy |
747,880
+126,226
| +20% | +$29M | 0.39% | 51 |
|
|
2019
Q4 | $136M | Sell |
621,654
-75,480
| -11% | -$15.3M | 0.2% | 113 |
|
|
2019
Q3 | $118M | Buy |
697,134
+60,438
| +9% | +$10.7M | 0.19% | 115 |
|
|
2019
Q2 | $117M | Buy |
636,696
+111,567
| +21% | +$19.5M | 0.18% | 114 |
|
|
2019
Q1 | $96.6M | Buy |
525,129
+196,761
| +60% | +$36.3M | 0.16% | 132 |
|
|
2018
Q4 | $54.4M | Sell |
328,368
-577,159
| -64% | -$100M | 0.1% | 207 |
|
|
2018
Q3 | $175M | Buy |
905,527
+593,667
| +190% | +$106M | 0.26% | 84 |
|
|
2018
Q2 | $53M | Buy |
311,860
+32,535
| +12% | +$5.04M | 0.08% | 273 |
|
|
2018
Q1 | $45.5M | Sell |
279,325
-67,930
| -20% | -$11.1M | 0.07% | 316 |
|
|
2017
Q4 | $52M | Buy |
347,255
+670
| +0.2% | +$99.2K | 0.07% | 309 |
|
|
2017
Q3 | $52.7M | Sell |
346,585
-98,140
| -22% | -$14.8M | 0.08% | 293 |
|
|
2017
Q2 | $57.3M | Buy |
444,725
+50,350
| +13% | +$6.06M | 0.09% | 265 |
|
|
2017
Q1 | $43.1M | Sell |
394,375
-158,130
| -29% | -$13.9M | 0.07% | 314 |
|
|
2016
Q4 | $40.7M | Sell |
552,505
-73,980
| -12% | -$6.02M | 0.07% | 326 |
|
|
2016
Q3 | $54.6M | Buy |
626,485
+106,808
| +21% | +$10.1M | 0.09% | 238 |
|
|
2016
Q2 | $44.7M | Buy |
519,677
+23,460
| +5% | +$2.03M | 0.08% | 274 |
|
|
2016
Q1 | $39.4M | Buy |
496,217
+185,800
| +60% | +$16.8M | 0.07% | 283 |
|
|
2015
Q4 | $39.1M | Buy |
310,417
+7,670
| +3% | +$926K | 0.07% | 286 |
|
|
2015
Q3 | $31.5M | Sell |
302,747
-9,090
| -3% | -$1.17M | 0.06% | 330 |
|
|
2015
Q2 | $38.5M | Sell |
311,837
-1,300
| -0.4% | -$164K | 0.07% | 309 |
|
|
2015
Q1 | $36.9M | Buy |
313,137
+4,290
| +1% | +$514K | 0.06% | 336 |
|
|
2014
Q4 | $36.7M | Sell |
308,847
-5,780
| -2% | -$651K | 0.07% | 312 |
|
|
2014
Q3 | $35.3M | Sell |
314,627
-30,537
| -9% | -$2.91M | 0.07% | 307 |
|
|
2014
Q2 | $32.7M | Buy |
345,164
+15,757
| +5% | +$1.1M | 0.06% | 330 |
|
|
2014
Q1 | $23.3M | Buy |
329,407
+41,300
| +14% | +$3.27M | 0.04% | 427 |
|
|
2013
Q4 | $21.4M | Sell |
288,107
-196,800
| -41% | -$13.7M | 0.04% | 432 |
|
|
2013
Q3 | $36.8M | Buy |
484,907
+186,447
| +62% | +$14.8M | 0.08% | 256 |
|
|
2013
Q2 | $23.8M | Buy |
+298,460
| New | +$22M | 0.05% | 359 |
|
Other funds holding VRTX
Prudential Financial's VRTX Position: Q2 2026 in Review
Prudential Financial increased its Vertex Pharmaceuticals (VRTX) stake by 1.3% in Q2 2026, buying an estimated $768K and bringing the position to 133,294 shares worth $66.2M. The position accounts for 0.07% of the portfolio, ranked #194.
Prudential Financial first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $209M in Q2 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Prudential Financial held 133,294 shares of Vertex Pharmaceuticals worth $66.2M as of Q2 2026.
- Prudential Financial bought 1,734 Vertex Pharmaceuticals shares in Q2 2026, an estimated $768K.
- Vertex Pharmaceuticals made up 0.07% of Prudential Financial's portfolio in Q2 2026, its #194 holding.
- Prudential Financial first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Prudential Financial's Vertex Pharmaceuticals position peaked at $209M in Q2 2020.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.